Mobile-Based Application "MyChoices"

HIV Clinical Trial

Official title:

Mobile-Based Application "MyChoices" to Increase Uptake of HIV Testing, Detection of New HIV Infections, and Linkage to Care and Prevention Services by Young Men Who Have Sex With Men

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03179319
• Other study ID #: 1U19HD089881 (SubProject 8784)
• Secondary ID: 1U19HD089881
• Status: Completed
• Phase: N/A
• Start date: July 1, 2017
• Est. completion date: January 31, 2020

Study information

• Verified date: November 2020
• Source: Fenway Community Health
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study is testing the acceptability and feasibility of MyChoices, a mobile application (app), to promote HIV testing and pre-exposure prophylaxis (PrEP) uptake among young men who have sex with men (YMSM).

Description:

"MyChoices", an app adapted from HealthMindr and developed using iterative feedback from youth, is being refined to to maximize acceptability among YMSM. "MyChoices" was guided by the Social Cognitive Theory (SCT) model and includes three major functions that are designed to promote self-efficacy, self-regulation, goal-setting and environmental influences in order to impact behavior change. (1) Tracking and Self-Monitoring HIV Risk: In order to target self-regulation, brief surveys within the app are used to assess behavioral patterns of YMSM, particularly around sexual relationships, which are then used to help customize the app for each user. (2) HIV and sexually transmitted infection (STI) Prevention Information: In order to improve self-efficacy for HIV testing and HIV prevention overall, quizzes and infographics that appeal to YMSM have been incorporated into the app, focusing on promotion of HIV prevention and regular HIV testing. The app also allows users to order OraQuick HIV home testing kits and STI home collection kits (for rectal and urethral gonorrhea and Chlamydia and syphilis). Additionally, the app includes information on testing sites and local PrEP clinics (e.g., telephone, address, hours of testing, etc), and external links to specific site webpages that are near the user (determined using GPS technology). (3) HIV Testing Plan: Acknowledging the central role of goal setting and environmental influences on health behavior, the app allows users to create a HIV testing plan by allowing them to compare and choose different screening options (e.g., home self-testing, antigen, rapid). Questions about HIV transmission behaviors and testing history are then asked to create a tailored testing plan. After a HIV testing plan is developed, users have the option to customize reminders for the timeframe selected (e.g., user is pinged every 3 months as a reminder to get tested). Users are able to select from a list of phrases or create their own to ensure privacy. Moreover, geofencing technology allows users to be notified when in the vicinity of testing locations, based on the Geo Positioning System (GPS) location, during the testing timeframe.

This study is part of the iTech NIH U19, which has an overall goal to develop innovative technology-focused interventions addressing the HIV prevention and care continuum for youth.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: January 31, 2020
• Est. primary completion date: December 28, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 15 Years to 24 Years

Eligibility

Inclusion Criteria:

• No HIV test in the past 3 months (self-reported).

• Not known to be HIV-infected (self-reported).

• Not currently taking PrEP (self-report).

• Owns or leases a phone with Android platform (for Aims 2 and 3) or iOS platform (Aim 3 only), has an active data plan, and willing to download the MyChoices application.

• Willing to attend an in-person baseline study visit in Boston or the Bronx and complete online follow-up visits.

• Able to understand, read, and speak English.

• Participants ages 15-18: self-report at least one episode of anal intercourse with a male or transfemale partner during the last 6 months.

• Participants ages 19-24: self-report evidence of high risk for acquiring HIV infection including at least one of the following:

1. at least one episode of condomless anal intercourse with an HIV-infected or unknown HIV status male or transfemale partner during the last 6 months; or

2. anal intercourse with 2 or more male or transfemale sex partners during the last 6 months; or

3. exchange of money, gifts, shelter, or drugs for anal sex with a male or transfemale partner during the last 6 months; or

4. sex with a male or transfemale partner and has had an STI during the last 6 months.

Exclusion Criteria:

• Any health condition that may interfere with participation or the ability to provide informed consent, including any debilitating or life-threatening conditions.

• Prior enrollment in an HIV vaccine trial with receipt of experimental vaccine product and evidence of vaccine-induced seropositivity.

• Known to be HIV-infected.

• Any medical, psychiatric, or social condition or other responsibilities that, in the judgment of the investigator, would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.

Related Conditions & MeSH terms

• HIV
• Pre-exposure Prophylaxis
• Risk Reduction
• Sexually Transmitted Diseases

Intervention

Behavioral:
• MyChoices
Access to the MyChoices mobile app which includes the HIV test plan with reminders, STI information, PrEP resources, links to testing and PrEP sites, and geo-location features.

Locations

Country	Name	City	State
United States	Fenway Health Center	Boston	Massachusetts
United States	Montefiore Medical Center	Bronx	New York

Sponsors (5)

Lead Sponsor	Collaborator
Fenway Community Health	Brown University, Emory University, Montefiore Medical Center, University of North Carolina

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Acceptability: System Usability Scale	System Usability Scale: a validated scale that assesses subjective usability of a system, or, in this case, an app. The System Usability Scale consists of a 10 item questionnaire with five response options; from Strongly agree to Strongly disagree. The items scores are converted into a score from 0 (negative) to 100 (positive). A score of =50 indicates that the app is acceptable, and a score above 68 is considered above average.	3 months
Primary	Feasibility: Frequency of Logins	Number of individuals who logged into app at least one time after set up	3 months
Secondary	Preliminary Efficacy: Number of Participants Self-reported Having Tested for HIV	Self-report having tested for HIV over follow up	6 months
Secondary	Preliminary Efficacy: Number of Participants Self-reported Having Initiated PrEP	Self-report of participants reporting PrEP initiation anytime over study follow up	6 months
Secondary	Number of Times Participants Used Distinct App Components	The total number of times that participants selected distinct components (e.g., testing plan, ordering, FAQs) of the app were summed	3 months
Secondary	App Content and Functionality Most Utilized	We a priori identified the primary app components (i.e., HIV test plan, location search, ordering supplies, FAQs) and report the number of participants using these app components at least once over follow up	3 months
Secondary	Number of HIV Home Testing Kits Ordered	Number of Participants who ordered at least one HIV home testing kit over follow up	6 months